Literature DB >> 28920923

All TIEd up: mechanisms of Schlemm's canal maintenance.

Jeremiah Bernier-Latmani1, Tatiana V Petrova1,2.   

Abstract

Glaucoma is a leading cause of blindness, with an estimated world-wide prevalence of 3.5% in members of the population older than 40 years of age. Elevated intraocular pressure as the result of abnormal resistance to aqueous humor drainage is a major contributing, and the only preventable, factor in glaucoma development. Schlemm's canal (SC), a lymphatic-like vessel encircling the anterior portion of the eye, plays a key role in promoting aqueous humor outflow and maintenance of normal intraocular pressure. The risk of developing glaucoma increases with age; therefore, understanding mechanisms of SC maintenance and how aging affects SC function are of special importance, both for prevention and novel treatment approaches to glaucoma. Using a compelling array of genetic models, Kim et al. report in this issue of the JCI that continuous angiopoietin/TIE2 signaling is required for maintaining SC identity and integrity during adulthood and show that its age-related changes can be rescued by a TIE2 agonistic antibody.

Entities:  

Mesh:

Year:  2017        PMID: 28920923      PMCID: PMC5617675          DOI: 10.1172/JCI96840

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

Review 1.  Schlemm's canal endothelia, lymphatic, or blood vasculature?

Authors:  Renata F Ramos; James B Hoying; Marlys H Witte; W Daniel Stamer
Journal:  J Glaucoma       Date:  2007 Jun-Jul       Impact factor: 2.503

2.  Lymphatic regulator PROX1 determines Schlemm's canal integrity and identity.

Authors:  Dae-Young Park; Junyeop Lee; Intae Park; Dongwon Choi; Sunju Lee; Sukhyun Song; Yoonha Hwang; Ki Yong Hong; Yoshikazu Nakaoka; Taija Makinen; Pilhan Kim; Kari Alitalo; Young-Kwon Hong; Gou Young Koh
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

3.  Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.

Authors:  Tomokazu Souma; Stuart W Tompson; Benjamin R Thomson; Owen M Siggs; Krishnakumar Kizhatil; Shinji Yamaguchi; Liang Feng; Vachiranee Limviphuvadh; Kristina N Whisenhunt; Sebastian Maurer-Stroh; Tammy L Yanovitch; Luba Kalaydjieva; Dimitar N Azmanov; Simone Finzi; Lucia Mauri; Shahrbanou Javadiyan; Emmanuelle Souzeau; Tiger Zhou; Alex W Hewitt; Bethany Kloss; Kathryn P Burdon; David A Mackey; Keri F Allen; Jonathan B Ruddle; Sing-Hui Lim; Steve Rozen; Khanh-Nhat Tran-Viet; Xiaorong Liu; Simon John; Janey L Wiggs; Francesca Pasutto; Jamie E Craig; Jing Jin; Susan E Quaggin; Terri L Young
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

4.  Endothelial ERK signaling controls lymphatic fate specification.

Authors:  Yong Deng; Deepak Atri; Anne Eichmann; Michael Simons
Journal:  J Clin Invest       Date:  2013-02-08       Impact factor: 14.808

Review 5.  Intestinal lymphatic vasculature: structure, mechanisms and functions.

Authors:  Jeremiah Bernier-Latmani; Tatiana V Petrova
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-06-28       Impact factor: 46.802

6.  A lymphatic defect causes ocular hypertension and glaucoma in mice.

Authors:  Benjamin R Thomson; Stefan Heinen; Marie Jeansson; Asish K Ghosh; Anees Fatima; Hoon-Ki Sung; Tuncer Onay; Hui Chen; Shinji Yamaguchi; Aris N Economides; Ann Flenniken; Nicholas W Gale; Young-Kwon Hong; Amani Fawzi; Xiaorong Liu; Tsutomu Kume; Susan E Quaggin
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

7.  The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel.

Authors:  Aleksanteri Aspelund; Tuomas Tammela; Salli Antila; Harri Nurmi; Veli-Matti Leppänen; Georgia Zarkada; Lukas Stanczuk; Mathias Francois; Taija Mäkinen; Pipsa Saharinen; Ilkka Immonen; Kari Alitalo
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

8.  A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy.

Authors:  René Hägerling; Cathrin Pollmann; Martin Andreas; Christian Schmidt; Harri Nurmi; Ralf H Adams; Kari Alitalo; Volker Andresen; Stefan Schulte-Merker; Friedemann Kiefer
Journal:  EMBO J       Date:  2013-01-08       Impact factor: 11.598

Review 9.  A Closer Look at Schlemm's Canal Cell Physiology: Implications for Biomimetics.

Authors:  Cula N Dautriche; Yangzi Tian; Yubing Xie; Susan T Sharfstein
Journal:  J Funct Biomater       Date:  2015-09-21

10.  Novel characterization and live imaging of Schlemm's canal expressing Prox-1.

Authors:  Tan N Truong; Hannah Li; Young-Kwon Hong; Lu Chen
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more
  5 in total

1.  Overexpression and Activation of αvβ3 Integrin Differentially Affects TGFβ2 Signaling in Human Trabecular Meshwork Cells.

Authors:  Mark S Filla; Kristy K Meyer; Jennifer A Faralli; Donna M Peters
Journal:  Cells       Date:  2021-07-29       Impact factor: 6.600

2.  Tie2 Activation via VE-PTP Inhibition With Razuprotafib as an Adjunct to Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension.

Authors:  Mitchell Brigell; Barbara Withers; Akshay Buch; Kevin G Peters
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

Review 3.  Minimally Invasive Glaucoma Surgery: What Do We Know? Where Should We Go?

Authors:  Chen Xin; Huangzhou Wang; Ningli Wang
Journal:  Transl Vis Sci Technol       Date:  2020-04-23       Impact factor: 3.283

4.  A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure.

Authors:  Guorong Li; Astrid F Nottebaum; Mitchell Brigell; Iris D Navarro; Ute Ipe; Sarthak Mishra; Maria Gomez-Caraballo; Heather Schmitt; Brandi Soldo; Steve Pakola; Barbara Withers; Kevin G Peters; Dietmar Vestweber; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.925

5.  Angiopoietin-1 Mimetic Nanoparticles for Restoring the Function of Endothelial Cells as Potential Therapeutic for Glaucoma.

Authors:  Raphael Mietzner; Ramona Pawlak; Ernst R Tamm; Achim Goepferich; Rudolf Fuchshofer; Miriam Breunig
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.